Intervention

Atorvastatin calcium

ClinicalTrials.gov intervention label

Clinical trials4

Recruiting1

Common conditions6

Lead sponsors shown3

Clinical trials

4 shown

Phase I Drug-Drug Interaction Study of UBT251 Injection in Participants With Overweight or ObesityNCT07785934 · 2026-05-27

Lipitor as a Treatment for Alzheimer's DiseaseNCT00024531 · 2000-10-01

A Study on Possible Interactions Between Protease Inhibitors (Anti-HIV Drugs) and Drugs Which Lower the Level of Fat in Your BloodNCT00000941

The Effect of Efavirenz and Nelfinavir on the Blood Levels of Certain Lipid-Lowering DrugsNCT00017758

Common conditions

HIV Infections2 Alzheimer Disease1 Drug Drug Interaction (DDI)1 HIV Seronegativity1 Lipodystrophy1 Pharmacokinetics and Pharmacodynamics1

Leading sponsors

National Institute of Allergy and Infectious Diseases (NIAID)2 Institute for the Study of Aging (ISOA)1 The United Bio-Technology (Hengqin) Co., Ltd.1

Trial status mix

COMPLETED3

RECRUITING1

Phase mix

PHASE13

PHASE21

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.